LOXO ONCOLOGY INC. news, videos and press releases
For more news please use our advanced search feature.
LOXO ONCOLOGY INC. - More news...
LOXO ONCOLOGY INC. - More news...
- WEISSLAW LLP: Loxo Oncology, Inc. Acquisition May Not Be In The Best Interests of LOXO Shareholders
- Loxo Oncology Inc to Host Earnings Call
- SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Loxo Oncology, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
- Loxo Oncology Announces the Closing of its Follow-On Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
- Loxo Oncology Prices Follow-On Offering of Common Stock
- Loxo Oncology Announces Proposed Public Offering of Common Stock
- Loxo Oncology Outlines Plans for Accelerated Path to U.S. FDA Approval for Larotrectinib (LOXO-101) and Provides Comprehensive Pipeline Update
- Loxo Oncology TRK Inhibitor Larotrectinib (LOXO-101) Shows Durable Anti-Tumor Activity Across TRK Fusion Cancers in ESMO Asia Phase 1 Update
- Loxo Oncology to Present Updated LOXO-101 Adult Phase 1 Data at the European Society for Medical Oncology (ESMO) Asia Congress
- Loxo Oncology to Present Preclinical Data for LOXO-292 and LOXO-195 at the 28th EORTC-NCI-AACR Symposium
- Loxo Oncology Appoints Steve D. Harr, M.D., CFO of Juno Therapeutics, to Board of Directors
- Loxo Oncology to Present at the Stifel 2016 Healthcare Conference
- Loxo Oncology Announces Third Quarter 2016 Financial Results
- Loxo Oncology to Announce Third Quarter 2016 Financial Results
